Ketamine depression treatment
Pro Research Analysisby 
Searched over 200M research papers
Ketamine as a Treatment for Depression: A Comprehensive Review
Introduction to Ketamine and Depression Treatment
Depression is a leading cause of disability worldwide, with a significant portion of patients experiencing treatment-resistant depression (TRD) . Traditional antidepressants often take weeks to show effects, and about one-third of patients do not achieve recovery . Over the past two decades, ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has emerged as a potential rapid-acting antidepressant Corriger2019Marcantoni2020.
Rapid Antidepressant Effects of Ketamine
Intravenous Ketamine
Intravenous (IV) ketamine has shown rapid antidepressant effects, often within hours of administration. Studies indicate that a single infusion can produce significant improvements in depressive symptoms within 4 hours, peaking at 24 hours, and lasting up to 7 days Marcantoni2020Newport2015Singh2016. Multiple infusions can enhance and prolong these effects . However, the long-term safety and efficacy of repeated ketamine administration remain under-researched Marcantoni2020Newport2015.
Comparative Efficacy of Racemic Ketamine and Esketamine
Racemic ketamine and its enantiomer, esketamine, have both been studied for their antidepressant properties. Meta-analyses suggest that racemic ketamine may offer greater overall response and remission rates compared to esketamine, with fewer dropouts due to adverse events . Intravenous ketamine appears more effective than intranasal esketamine for treating depression .
Oral Ketamine: Accessibility and Efficacy
Oral ketamine is gaining attention due to its accessibility and ease of administration compared to IV ketamine. Preliminary evidence suggests that oral ketamine can significantly improve depressive symptoms and is generally well-tolerated without serious adverse events . However, more research is needed to confirm its long-term efficacy and safety, especially in treatment-resistant cases .
Ketamine vs. Electroconvulsive Therapy (ECT)
Ketamine has been compared to electroconvulsive therapy (ECT) for TRD. Studies indicate that ketamine may be non-inferior to ECT in terms of response rates, with fewer cognitive side effects . However, ECT remains a more established treatment with a longer track record of efficacy .
Safety and Tolerability
Ketamine is generally well-tolerated at low, single doses, with common side effects including transient dissociative symptoms, dizziness, and nausea Corriger2019Singh2016. The safety profile of repeated or higher doses is less well understood, necessitating further research Corriger2019Marcantoni2020Newport2015.
Conclusion
Ketamine shows promise as a rapid-acting antidepressant, particularly for treatment-resistant depression. While IV ketamine has demonstrated significant short-term benefits, the long-term safety and efficacy of repeated doses require further investigation. Oral ketamine offers a more accessible alternative but also needs more robust research to establish its effectiveness. Comparisons with ECT suggest that ketamine could be a viable option with fewer cognitive side effects. Overall, ketamine represents a significant advancement in depression treatment, but more research is needed to fully understand its potential and limitations.
Sources and full results
Most relevant research papers on this topic